Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential-Reference-Cited by-同舟云学术

Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential

Published:2023-02-02 Issue:3 Volume:21 Page:235-242
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Russo Andrew T.¹,Grosenbach Douglas W.¹,Honeychurch Kady M.¹,Long Paul G.¹,Hruby Dennis E.¹

Affiliation:

1. SIGA Technologies, Inc, Corvallis, OR, USA

Funder

Biomedical Advanced Research and Development Authority

the National Institute of Allergy and Infectious Diseases

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2023.2170350

Reference47 articles.

1. Smallpox eradication

2. Diagnosis and Management of Smallpox

3. Alarm over biosafety blunders

4. Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human monkeypox virus: Epidemiologic review and research progress in diagnosis and treatment;Journal of Clinical Virology;2024-04

2. Early administration of tecovirimat shortens the time to mpox clearance in a model of human infection;PLOS Biology;2023-12-21

3. Clinical Predictors of Monkeypox Diagnosis: A Case-Control Study in a Nonendemic Region during the 2022 Outbreak;Microorganisms;2023-09-11

4. In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat;Memórias do Instituto Oswaldo Cruz;2023